|
Volumn 329, Issue 7473, 2004, Pages 999-
|
What's the evidence that NICE guidance has been implemented? Results from a national evaluation using time series analysis, audit of patients' notes, and interviews
|
Author keywords
[No Author keywords available]
|
Indexed keywords
DOCETAXEL;
GEMCITABINE;
PACLITAXEL;
TAXANE DERIVATIVE;
TETRAHYDROLIPSTATIN;
ZANAMIVIR;
ALZHEIMER DISEASE;
ANAMNESIS;
BREAST CANCER;
CANCER SURGERY;
COLORECTAL CANCER;
CONTROLLED STUDY;
COST BENEFIT ANALYSIS;
DEFIBRILLATOR;
DEVICE;
EVIDENCE BASED MEDICINE;
FEMALE;
HEARING AID;
HERNIOPLASTY;
HIP PROSTHESIS;
HOSPITAL;
HUMAN;
INFLUENZA;
INGUINAL HERNIA;
LAPAROSCOPIC SURGERY;
MAJOR CLINICAL STUDY;
MEDICAL RECORD;
MOLAR TOOTH;
OBESITY;
OVARY CANCER;
PRACTICE GUIDELINE;
PRESCRIPTION;
PRIORITY JOURNAL;
PROPHYLAXIS;
REVIEW;
TIME SERIES ANALYSIS;
TOOTH EXTRACTION;
ARTICLE;
BIOMEDICAL TECHNOLOGY ASSESSMENT;
ECONOMICS;
HEALTH CARE QUALITY;
MEDICAL AUDIT;
NATIONAL HEALTH SERVICE;
STANDARD;
UNITED KINGDOM;
FEMALE;
GREAT BRITAIN;
GUIDELINE ADHERENCE;
HUMANS;
MEDICAL AUDIT;
PRACTICE GUIDELINES;
QUALITY OF HEALTH CARE;
STATE MEDICINE;
TECHNOLOGY ASSESSMENT, BIOMEDICAL;
|
EID: 8444248351
PISSN: 09598138
EISSN: 14685833
Source Type: Journal
DOI: 10.1136/bmj.329.7473.999 Document Type: Article |
Times cited : (358)
|
References (17)
|